Clinical Trials Directory

Trials / Completed

CompletedNCT02310035

Observational Study on the Course of Plasma Glutamine Levels During Critical Illness

Observational Study on the Course of Plasma Glutamine Levels During Critial Illness

Status
Completed
Phase
Study type
Observational
Enrollment
178 (actual)
Sponsor
Frisius Medisch Centrum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission

Detailed description

All patients who are admitted to the ICU after elective surgery and non-elective admissions. In both groups a total of 80 patients will be included. (In the trials we mentioned in the introduction 80, 174 and 66 patients were included. In the study performed by Oudemans-van Straaten a decent distribution between lower and higher levels of glutamine was achieved in 80 non-elective patients.) Exclusion criteria are patients younger then 18 years and patients who need total parenteral nutrition (TPN). The patients will receive standard care during their treatment on the ICU. Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission. Hereafter plasma glutamine will be measured daily, a plasma sample will be taken from a standard evaluation blood sample at 6.00 am during admission on the ICU.

Conditions

Timeline

Start date
2014-04-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2014-12-05
Last updated
2015-05-13

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02310035. Inclusion in this directory is not an endorsement.